SRRK - Scholar Rock Holding Corporation
NEXT EARNINGS:
Mar 3, 2026
(in 6 days)
EPS Est: $-0.88
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$54.20
DETAILS
HIGH:
$60.00
LOW:
$50.00
MEDIAN:
$52.00
CONSENSUS:
$54.20
UPSIDE:
15.27%
Market Cap:
4.80B
Volume:
450,303
Avg Volume:
1,243,748
52 Week Range:
22.71-49.82
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.70
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
128
IPO Date:
2018-05-25
EPS (TTM):
-2.47
P/E Ratio:
-17.52
Revenue (TTM):
N/A
Total Assets:
474.92M
Total Debt:
65.13M
Cash & Equiv:
177.88M
Rev Growth (5Y):
-100.0%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-55.9%
Debt/Equity:
0.18
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-14 | $-0.90 | $-0.84 | -7.8% | — | $50000 | — |
| 2025-08-06 | $-0.98 | $-0.66 | -48.5% | — | $55560 | — |
| 2025-05-14 | $-0.67 | $-0.63 | -6.3% | — | — | — |
| 2025-02-27 | $-0.60 | $-0.60 | 0.0% | — | — | — |
| 2024-11-12 | $-0.66 | $-0.58 | -13.8% | — | — | — |
| 2024-08-08 | $-0.60 | $-0.61 | +1.6% | — | — | — |
| 2024-05-07 | $-0.59 | $-0.51 | -15.7% | — | — | — |
| 2024-03-19 | $-0.50 | $-0.49 | -2.0% | $11.7M | — | — |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 33.19M | 18.82M | 15.40M | 20.49M | 0 | 0 | 379,000 |
| Net Income | (246.29M) | (165.79M) | (134.50M) | (131.80M) | (86.48M) | (51.00M) | (49.33M) | (25.00M) | (16.21M) |
| EPS | -2.47 | -1.99 | -2.21 | -3.59 | -2.77 | -1.80 | -3.15 | -1.40 | -0.91 |
| Total Assets | 474.92M | 311.04M | 358.17M | 304.44M | 388.31M | 196.38M | 181.34M | 61.64M | 32.78M |
| Total Debt | 65.13M | 61.82M | 69.40M | 84.47M | 57.14M | 5.30M | 462,000 | 1.04M | 1.67M |
| Cash & Equivalents | 177.88M | 101.86M | 103.28M | 212.84M | 160.36M | 36.31M | 115.07M | 56.46M | 10.03M |
| Operating Cash Flow | (200.95M) | (145.23M) | (132.69M) | (126.79M) | (60.27M) | (63.12M) | 24.57M | (21.74M) | (15.14M) |
| Free Cash Flow | (201.05M) | (145.30M) | (133.76M) | (132.04M) | (64.36M) | (66.23M) | 23.08M | (22.10M) | (15.94M) |
| FCF per Share | -2.01 | -1.91 | -2.24 | -3.60 | -2.09 | -2.41 | 1.47 | -1.23 | -0.89 |
| Book Value | 368.63M | 225.22M | 260.24M | 172.07M | 260.77M | 112.90M | 106.62M | (53.52M) | (30.03M) |
| Cash & ST Investments | 437.28M | 279.94M | 315.36M | 252.99M | 341.03M | 157.45M | 175.65M | 57.96M | 28.04M |
| ROC Equity | -0.67 | -0.74 | -0.52 | -0.77 | -0.33 | -0.45 | -0.46 | N/A | N/A |